57 related articles for article (PubMed ID: 7462385)
1. The plasma aldosterone response to angiotensin II infusion in aldosterone-producing adenoma and idiopathic hyperaldosteronism.
Wisgerhof M; Brown RD; Hogan MJ; Carpenter PC; Edis AJ
J Clin Endocrinol Metab; 1981 Feb; 52(2):195-8. PubMed ID: 7462385
[TBL] [Abstract][Full Text] [Related]
2. Measurement of peripheral plasma 18-oxocortisol can discriminate unilateral adenoma from bilateral diseases in patients with primary aldosteronism.
Satoh F; Morimoto R; Ono Y; Iwakura Y; Omata K; Kudo M; Takase K; Seiji K; Sasamoto H; Honma S; Okuyama M; Yamashita K; Gomez-Sanchez CE; Rainey WE; Arai Y; Sasano H; Nakamura Y; Ito S
Hypertension; 2015 May; 65(5):1096-102. PubMed ID: 25776074
[TBL] [Abstract][Full Text] [Related]
3. Utility of 18-hydroxycortisol and 18-oxocortisol: potential markers of aldosterone-producing adenomas.
Ozeki Y; Shibata H
Hypertens Res; 2023 Oct; 46(10):2433-2435. PubMed ID: 37582850
[No Abstract] [Full Text] [Related]
4. Reduction of Proteinuria in a Patient With Primary Aldosteronism by Angiotensin II Receptor Blocker Administration.
Rikitake J; Ashida K; Miura M; Nomura M
JCEM Case Rep; 2023 Jan; 1(1):luac021. PubMed ID: 37908267
[TBL] [Abstract][Full Text] [Related]
5. Idiopathic edema. Report of a case with orthostatic edema and hyperaldosteronism.
Hill SR; Hood WG; Farmer TA; Burnum JF
N Engl J Med; 1960 Dec; 263():1342-5. PubMed ID: 13714321
[No Abstract] [Full Text] [Related]
6. Extracellular Vesicles as Biomarkers and Biovectors in Primary Aldosteronism.
Neves KB; Touyz RM
Hypertension; 2019 Aug; 74(2):250-252. PubMed ID: 31230536
[No Abstract] [Full Text] [Related]
7. Aldosterone-producing Adenoma: Considerations on in Vitro Effects of Adrenal Thermoablation and its in Vivo Application.
Armanini D; Bordin L; Sabbadin C
Endocrinology; 2023 Jun; 164(8):. PubMed ID: 37439222
[No Abstract] [Full Text] [Related]
8. Outcome of Surgery for Primary Hyperaldosteronism.
Liao CH; Wu V; Jeff Chueh S; Sankari BR
World J Surg; 2012 May; 36(5):1209-1210. PubMed ID: 22286966
[No Abstract] [Full Text] [Related]
9. Intrinsic Adrenal TWIK-Related Acid-Sensitive TASK Channel Dysfunction Produces Spontaneous Calcium Oscillations Sufficient to Drive AngII (Angiotensin II)-Unresponsive Hyperaldosteronism.
Gancayco CA; Gerding MR; Breault DT; Beenhakker MP; Barrett PQ; Guagliardo NA
Hypertension; 2022 Nov; 79(11):2552-2564. PubMed ID: 36129175
[TBL] [Abstract][Full Text] [Related]
10. Adrenal Venous Sampling Could Be Omitted before Surgery in Patients with Conn's Adenoma Confirmed by Computed Tomography and Higher Normal Aldosterone Concentration after Saline Infusion Test.
Holaj R; Waldauf P; Wichterle D; Kvasnička J; Zelinka T; Petrák O; Krátká Z; Forejtová L; Kaván J; Widimský J
Diagnostics (Basel); 2022 Jul; 12(7):. PubMed ID: 35885622
[TBL] [Abstract][Full Text] [Related]
11. Reassessment of Postural Stimulation Testing as a Simple Tool to Identify a Subgroup of Patients With Unilateral Primary Aldosteronism.
Teresa Fuss C; Brohm K; Fassnacht M; Kroiss M; Hahner S
J Clin Endocrinol Metab; 2022 Jan; 107(2):e865-e873. PubMed ID: 34415988
[TBL] [Abstract][Full Text] [Related]
12. Adrenal Tissue-Specific Deletion of TASK Channels Causes Aldosterone-Driven Angiotensin II-Independent Hypertension.
Guagliardo NA; Yao J; Stipes EJ; Cechova S; Le TH; Bayliss DA; Breault DT; Barrett PQ
Hypertension; 2019 Feb; 73(2):407-414. PubMed ID: 30580687
[TBL] [Abstract][Full Text] [Related]
13. Molecular and genetic aspects of guanylyl cyclase natriuretic peptide receptor-A in regulation of blood pressure and renal function.
Pandey KN
Physiol Genomics; 2018 Nov; 50(11):913-928. PubMed ID: 30169131
[TBL] [Abstract][Full Text] [Related]
14. Role of endogenous ACTH on circadian aldosterone rhythm in patients with primary aldosteronism.
Sonoyama T; Sone M; Tamura N; Honda K; Taura D; Kojima K; Fukuda Y; Kanamoto N; Miura M; Yasoda A; Arai H; Itoh H; Nakao K
Endocr Connect; 2014 Dec; 3(4):173-9. PubMed ID: 25239966
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune mechanisms activating the angiotensin AT1 receptor in 'primary' aldosteronism.
Kem DC; Li H; Velarde-Miranda C; Liles C; Vanderlinde-Wood M; Galloway A; Khan M; Zillner C; Benbrook A; Rao V; Gomez-Sanchez CE; Cunningham MW; Yu X
J Clin Endocrinol Metab; 2014 May; 99(5):1790-7. PubMed ID: 24552217
[TBL] [Abstract][Full Text] [Related]
16. Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis.
Oki K; Plonczynski MW; Luis Lam M; Gomez-Sanchez EP; Gomez-Sanchez CE
Endocrinology; 2012 Apr; 153(4):1774-82. PubMed ID: 22315453
[TBL] [Abstract][Full Text] [Related]
17. Progress in primary aldosteronism: present challenges and perspectives.
Gomez-Sanchez CE; Rossi GP; Fallo F; Mannelli M
Horm Metab Res; 2010 Jun; 42(6):374-81. PubMed ID: 20091458
[TBL] [Abstract][Full Text] [Related]
18. Emerging roles for two-pore-domain potassium channels and their potential therapeutic impact.
Bayliss DA; Barrett PQ
Trends Pharmacol Sci; 2008 Nov; 29(11):566-75. PubMed ID: 18823665
[TBL] [Abstract][Full Text] [Related]
19. TASK channel deletion in mice causes primary hyperaldosteronism.
Davies LA; Hu C; Guagliardo NA; Sen N; Chen X; Talley EM; Carey RM; Bayliss DA; Barrett PQ
Proc Natl Acad Sci U S A; 2008 Feb; 105(6):2203-8. PubMed ID: 18250325
[TBL] [Abstract][Full Text] [Related]
20. Primary aldosteronism.
Gordon RD
J Endocrinol Invest; 1995; 18(7):495-511. PubMed ID: 9221268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
